Table 1.
Clinical characteristics of the study participants
| Sex (male/female) | 47/25 |
| Age (years) | 63.2 ± 9.85 |
| BMI (kg/m2) | 23.3 ± 3.40 (54) |
| Systolic blood pressure (mmHg) | 128.1 ± 23.9 (63) |
| Diastolic blood pressure (mmHg) | 68.7 ± 11.8 (63) |
| eGFR (mL/min/1.73 m2) | 53.6 ± 24.6 (69) |
| Preoperative HbA1c (%) | 7.24 ± 1.27 (68) |
| 3M‐before HbA1c (%) | 7.47 ± 1.27 (38) |
| Decrease HbA1c (%) | 0.18 ± 1.08 (37) |
| Preoperative FBS (mg/dL) | 118.3 ± 27.4 (52) |
| Mean blood glucose level before meal within 1 week after surgery (mg/dL) | 142.4 ± 25.8 (61) |
| Incidence of hypoglycemia within 1 week after surgery (0/1/2–3) | 50/8/2 |
| Diabetes management (diet/oral hypoglycemic agents/insulin) | 6/31/30 |
| History of cardiovascular disease (yes/no) | 17/51 |
| Treatment with antiplatelet drugs (yes/no) | 15/53 |
| Treatment with antihypertensive drugs (yes/no) | 44/24 |
Data are mean ± standard deviation and/or number of participants. 3M‐before HbA1c, hemoglobin A1c at 12 weeks before surgery; BMI, body mass index; Decrease HbA1c, decrease in HbA1c before surgery; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; Preoperative FBS, preoperative fasting blood sugar; Preoperative HbA1c, hemoglobin A1c within 4 weeks before surgery.